The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on meeting demand for the drug in the world's most populous country.

Houston-based Empower Pharmacy rejected Eli Lilly's claims of false advertising in a New Jersey federal court.

Eli Lilly and Co. is considering Houston as a location for one of its four planned new U.S. manufacturing sites, with the Texas city potentially landing a $5.9 billion facility that could employ ...

Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing plant in Northeast Houston, according to documents filed with the state ...

Pharma giant Eli Lilly may plant a $5.9 billion manufacturing facility in Houston’s Generation Park, bringing serious biotech swagger to the region. The proposed project would create 600 permanent ...

Drugmaker Eli Lilly may build a $5.9 billion biomanufacturing plant off Beltway 8, creating hundreds of jobs. Here's what we know.

Houston Business Journal Major pharmaceutical manufacturer considers move into Houston Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.